Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis-Reference-Cited by-同舟云学术

Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis

Published:2009-01 Issue:1 Volume:121 Page:29-37
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Bhardwaj Suvercha,Vasishta R.K.,Arora Sunil K.

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference54 articles.

1. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes;Afrin;Infection and Immunity,1997

2. Elevated levels of interferon-γ, interleukin-10, and interleukin-6 during active disease in Indian kala azar;Ansari;Clinical Immunology,2006

3. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines;Arora;Experimental Parasitology,2005

4. Use of in vitro method to assess different brands of anti-leishmanial drugs;Arora;Medical Microbiology and Immunology,1991

5. Measurement of neutrophil function: phagocytosis, degranulation, the respiratory burst and bacterial killing;Babior,1981

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A T-Cell Epitope-Based Multi-Epitope Vaccine Designed Using Human HLA Specific T Cell Epitopes Induces a Near-Sterile Immunity against Experimental Visceral Leishmaniasis in Hamsters;Vaccines;2021-09-23

2. Hamster, a close model for visceral leishmaniasis: Opportunities and challenges;Parasite Immunology;2020-07-15

3. Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments;Vaccines;2019-10-18

4. Visceral leishmaniasis: An overview of vaccine adjuvants and their applications;Vaccine;2019-06

5. A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis;Cytokine;2018-11